文献速递其他结缔组织病

AP-1、RUNX和EGR染色质动态改变驱动人类纤维化肺病

Altered AP-1, RUNX, and EGR chromatin dynamics drive human fibrotic lung disease.
PubMed 文献 · Ann Rheum Dis · 2025-12-31

本研究对系统性硬化症相关间质性肺病(SSc-ILD)和对照肺组织进行单核ATAC/RNA多组学测序,利用ChromBPNet和HALO算法推断转录因子结合动态与调控网络。结果发现SSc-ILD成纤维细胞中AP-1、RUNX和EGR对促纤维化基因的结合与增强子活性增加,巨噬细胞中AP-1和bHLH-ZIP转录因子活性增强调控SPP1hi表型。

要点

  • SSc-ILD成纤维细胞中AP-1、RUNX和EGR增强子活性增加,驱动CTHRC1和ADAM12等促纤维化基因。
  • SSc-ILD巨噬细胞中AP-1和bHLH-ZIP转录因子结合增强,调控SPP1hi表型相关基因。
  • HALO算法揭示转录因子-调控元件-基因网络,确认AP-1、RUNX和EGR控制促纤维化基因程序。

核心结论

  • SSc-ILD肺纤维化中,AP-1、RUNX和EGR增强子驱动成纤维细胞促纤维化基因程序,bHLH-ZIP增强子调控SPP1hi巨噬细胞表型。

研究设计与样本

  • 对SSc-ILD和对照离体肺组织进行单核ATAC/RNA多组学测序,使用ChromBPNet和HALO算法分析成纤维细胞和巨噬细胞群体。

主要发现

  • ChromBPNet推断SSc-ILD成纤维细胞中AP-1、RUNX和EGR对促纤维化基因(如CTHRC1和ADAM12)的结合与增强子活性增加。
  • SSc-ILD巨噬细胞中AP-1和bHLH-ZIP转录因子对调控SPP1hi表型基因的结合与活性增强。
  • HALO确认AP-1、RUNX和EGR活性控制促纤维化基因程序。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pulmonary fibrosis can result from autoimmune, inflammatory, or idiopathic conditions, including systemic sclerosis-associated interstitial lung disease (SSc-ILD). Previous studies have implicated myofibroblasts and SPP1hi macrophages as drivers of fibrosis in lungs, as well as other tissues. Single-cell RNA-sequencing has delineated fibroblast and macrophage transcriptomes but provides limited insight into the transcriptional control of profibrotic gene programmes. METHODS: To determine the chromatin accessibility dynamics and transcription factors driving profibrotic gene programmes in human pulmonary fibrosis, we performed multiomic single-nucleus assay for transposase-accessible (ATAC)/RNA-sequencing on explanted SSc-ILD and control lungs. Using the neural network tool ChromBPNet, we analysed pseudobulk fibroblast and macrophage populations to infer transcription factor binding dynamics at single base-pair resolution. Hierarchical causal modelling for single-cell multiomics data (HALO), a novel algorithm developed to derive low-dimensional representations of sparse multiomics data, revealed transcription factor-regulatory element-gene networks. RESULTS: ChromBPNet inferred increased transcription factor binding to profibrotic genes, including CTHRC1 and ADAM12 in fibroblasts, and SPP1 and CCL18 in macrophages. SSc-ILD fibroblasts showed increased binding and enhancer activity by AP-1, RUNX, and EGR transcription factors to profibrotic genes, whereas macrophages displayed enhanced binding and activity of AP-1 and basic helix-loop-helix (bHLH)-ZIP transcription factors in genes regulating the SPP1hi phenotype. HALO confirmed AP-1, RUNX, and EGR activity controlling profibrotic gene programmes. CONCLUSIONS: These data provide comprehensive insights into the complexity of transcriptional control of SSc-ILD gene expression programmes and define specific AP-1, RUNX, and EGR enhancers in key myofibroblast marker genes CTHRC1 and ADAM12, and a bHLH-ZIP enhancer in SPP1hi macrophages.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Valenzi E, Jia M, Gerges P, et al. Altered AP-1, RUNX, and EGR chromatin dynamics drive human fibrotic lung disease. Ann Rheum Dis. 2025. PMID: 41478761. doi:10.1016/j.ard.2025.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。